About K Bell
Form D filings for Aerami Therapeutics in 2021 list K Bell as executive officer.
K Bell first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name K Bell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people K Bell works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D/A, Nov 4, 2021
TC
Timm Crowder
Executive officer
AW
Anne Whitaker
Director
JP
John Patton
Director
BW
Bill Welch
Director
AS
Adam Stern
Director
ST
Steve Thornton
Chief Executive Officer and director
DH
Darlene Deptula-Hicks
Director